Nicholls M G
Hypertension. 1979 May-Jun;1(3):228-34. doi: 10.1161/01.hyp.1.3.228.
What regulates the activity of the central nervous renin-angiotensin system is not known. To define whether control of this central system is linked to that in the periphery, simultaneous blood and cerebrospinal fluid (CSF) samples for measurement of immunoreactive angiotensin II were drawn from anesthetized dogs during hemorrhage, furosemide-induced volume depletion, insulin-hypoglycemia, beta-adrenergic blockade and saline infusion. Despite vigorous increments or decrements in plasma innunoreactive angiotensin II, CSF levels remained stable. Since immunoreactive angiotensin II in dog CSF is claimed to be mainly the heptapeptide des-Asp1-angiotensin II (angiotensin III), the possibility that the level of this peptide within CSF simply reflects plasma concentrations was assessed by infusing angiotensin III (2.5 and 25 ng/kg/min intravenously, each for 60 minutes) and monitoring plasma and CSF peptide levels. Whereas plasma immunoreactive angiotensin II levels increased appropriately across the infusions, no change in CSF levels was observed. These studies indicate the angiotensin III does not cross the blood-CSF barrier, at least in the short term.
中枢神经肾素-血管紧张素系统的活性受何调节尚不清楚。为了确定该中枢系统的调控是否与外周系统相关,在出血、速尿诱导的容量耗竭、胰岛素低血糖、β-肾上腺素能阻断和生理盐水输注期间,从麻醉犬身上同时采集血液和脑脊液(CSF)样本,以测量免疫反应性血管紧张素II。尽管血浆免疫反应性血管紧张素II有显著升高或降低,但脑脊液水平保持稳定。由于犬脑脊液中的免疫反应性血管紧张素II据称主要是七肽去天冬氨酸1-血管紧张素II(血管紧张素III),通过静脉输注血管紧张素III(2.5和25 ng/kg/分钟,各持续60分钟)并监测血浆和脑脊液中肽水平,评估了脑脊液中该肽水平是否仅反映血浆浓度这一可能性。虽然在输注过程中血浆免疫反应性血管紧张素II水平相应升高,但未观察到脑脊液水平有变化。这些研究表明,至少在短期内,血管紧张素III不会穿过血脑屏障。